Skip to main content
. 2021 May 11;12:628169. doi: 10.3389/fendo.2021.628169

Figure 2.

Figure 2

(A) Hormone supplementation and (B) Embryology parameters for patients in Groups I and II in the second cycle based on LHCGR (Asn312Ser) variations.